Madsen, Helen Nordahl8; Ekelund, Charlotte Kvist4; Tørring, Niels8; Ovesen, Per Glud9; Friis-Hansen, Lennart6; Ringholm Nielsen, Lene7; Petersen, Olav Bjørn9
1 Obstetrics and Gynaecology, Faculty of Health Sciences, Aarhus University, Aarhus University2 Department of clinical biochemistry, Faculty of Health Sciences, Aarhus University, Aarhus University3 Department of Clinical Medicine - Department of clinical biochemistry, Department of Clinical Medicine, Health, Aarhus University4 Klinik for føtalmedicin og ultralydskanning 4002, Rigshospitalet5 Department of Clinical Medicine - Department of Obstetrics and Gynaecology, Department of Clinical Medicine, Health, Aarhus University6 Klinisk-Biokemisk afdeling, Rigshospitalet7 Medicinsk-endokrin klinik, Center for gravide med diabetes, Rigshospitalet8 Department of Clinical Medicine - Department of clinical biochemistry, Department of Clinical Medicine, Health, Aarhus University9 Department of Clinical Medicine - Department of Obstetrics and Gynaecology, Department of Clinical Medicine, Health, Aarhus University
Objective: To determine the influence of type 1 diabetes mellitus (T1DM) on the first trimester serum markers of fetal aneuploidy; pregnancy-associated plasma protein-A (PAPP-A) and free beta subunit of human chorionic gonadotropin (free β-hCG) and to evaluate the influence of glycemic control on these parameters in the pregnant diabetic women. Design: Retrospective study. Setting: Data were extracted from electronic obstetric and laboratory databases at two Danish University Hospitals. Population: Based on 36,415 pregnancies without T1DM (non-T1DM) and 331 pregnancies with T1DM; β-hCG and PAPP-A were obtained at 8+0 to 14+2 gestational weeks. Methods: Medians for PAPP-A and free β-hCG were generated and Multiple of the normal gestation-specific Median (MoM) values were calculated for each separate pregnancy. After adjustment for maternal weight, ethnicity and smoking status, MoM values were compared across the T1DM and non-T1DM groups, respectively. Additionally, the relation between PAPP-A MoM and HgbA1C was examined in 348 T1DM pregnancies by Spearman’s rank correlation. Main outcome measure: Difference in biochemical marker levels between T1DM and non-T1DM. Results: PAPP-A was 0.86 MoM in T1DM pregnancies and 1.01 MoM in non-T1DM pregnancies, p<0.0001. Conversely, free β-hCG was not altered in T1DM pregnancies (T1DM 0.99 MoM, non-T1DM 0.98 MoM; p=0.14). There was a significant inverse correlation between HgbA1C and PAPP-A (rho=-0.12, p=0.02).
Acta Obstetricia Et Gynecologica Scandinavica, 2012, Vol 91, Issue 1, p. 57-61